secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVVITY, INC. (RVTY)
CIK:        0000031791
Form:       8-K
Filed at:   2021-08-12T23:59:59+00:00
Accession:  0001193125-21-244659
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PerkinElmer enters $500M delayed draw term loan to partly fund BioLegend acquisition
--------------------------------------------------------------------------------

- Unsecured term loan facility for $500M to fund portion of BioLegend acquisition, refinance BioLegend debt, and pay fees.
- Loan available until earlier of consummation of BioLegend acquisition or five business days after Oct 25, 2021 (possible extension to Jan 31, 2022).
- Matures on third anniversary of funding date; interest at base rate or eurocurrency rate plus spread based on debt rating.
- Concurrent $500M reduction in existing 364-day senior unsecured bridge term loan facility from Goldman Sachs.
- Covenants include debt-to-capitalization ratio (replaced by leverage/interest coverage if below investment grade) and customary events of default.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/31791/000119312521244659/0001193125-21-244659-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/31791/000119312521244659/d194876d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-244659

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer